PPLPHARMA — Piramal Pharma (Mumbai) Share News
0.000.00%
Last trade - 00:00- IN₹262.00bn
- IN₹304.53bn
- IN₹88.69bn
Brief: Piramal Pharma Says Fine Of Euros 182,001 Imposed On Unit By Audiencia Nacional, Spain
India's Piramal Pharma hits over 1-yr high on posting quarterly profit
Brief: Piramal Pharma Posts Dec-Quarter Consol Net PAT
Icici Securities Re: initiates India's Piramal Pharma; shares up
Brief: Piramal Pharma Says VetDC Initiated Civil Suit Making Claims In Relation To Batches Of Product Manufactured During 2018-2019 Against Unit
Focus: Indian drug manufacturers benefit from Big Pharma interest beyond China
India's Piramal Pharma margins may reach high-teens by FY26 - Jefferies
India's Piramal Pharma up after FDA closes inspection of US unit
India's Piramal Pharma surges on Q2 profit, analysts' positive view
Brief: Piramal Pharma Limited Announces Consolidated Results For Q2 And H1 FY2024
India's Piramal Pharma up on launching in-vitro biology capabilities
Brief: Piramal Pharma Says Piramal Pharma Solutions Launches In-Vitro Biology Capabilities At Ahmedabad Discovery Services Site
Brief: Piramal Pharma Says US FDA Conducted Gmp Inspection Of Co's Bethlehem Facility From Sept 18 To Sept 27
Brief: Piramal Pharma Says Voluntary Liquidation Of Unit Piramal Pharma Japan GK Approved By Authority
Brief: India's Piramal Pharma Ltd June-Quarter Consol Net Loss After Tax Narrows
India's Piramal Pharma jumps as Jefferies eyes margin growth in FY24
Brief: Plus Therapeutics Inc Says Announced An Expansion Of Its Collaboration With Piramal Pharma Solutions
India's Piramal Pharma up after FDA closes inspection of US plant
Brief: Piramal Pharma Says Successful Closure Of US FDA Inspection At Co Manufacturing Facility Located At Sellersville, USA